IgG <i>N-</i>Glycosylation from Patients with Pemphigus Treated with Rituximab.

Biomedicines · 2022 · PMC9330150 · PMID 35892674

Europe PMC DOI

hedged sentence

0.0830

closest p · 1.7× alpha

0.0830

boldest claim

The sentences

an increasing trendp = 0.083so close (0.05 < p ≤ 0.1)

75.4%; p = 0.016) ( Figure 3 A) with an increasing trend for the bi-galactosylated N -glycan structure (32.8% vs. 38.0%; p = 0.083), but not for the mono-galactosylated N -glycans (37.2% vs. 37.4%; p = 0.98) ( Figure 3 B,C).

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.